HUMAX-CD20, created in 2006 (Denmark), from 10 sister brands and 2214 competing brands. HUMAX-CD20 is a brand of Genmab, listed on the stock exchange of Etats-Unis. Its International Securities Identification Number (ISIN) is DK0010272202. HUMAX-CD20 belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Genmab
(HUMAX-CD20)
over 5 years*
USD 517.34